Yixintang Pharmaceutical Group Past Earnings Performance
Past criteria checks 2/6
Yixintang Pharmaceutical Group has been growing earnings at an average annual rate of 7.5%, while the Consumer Retailing industry saw earnings growing at 8.1% annually. Revenues have been growing at an average rate of 13.7% per year. Yixintang Pharmaceutical Group's return on equity is 6.9%, and it has net margins of 3.1%.
Key information
7.5%
Earnings growth rate
6.4%
EPS growth rate
| Consumer Retailing Industry Growth | 12.8% |
| Revenue growth rate | 13.7% |
| Return on equity | 6.9% |
| Net Margin | 3.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Yixintang Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 18,044 | 552 | 4,741 | 11 |
| 31 Dec 23 | 17,380 | 549 | 4,684 | 10 |
| 30 Sep 23 | 18,219 | 1,019 | 4,593 | 13 |
| 30 Jun 23 | 18,142 | 1,096 | 4,615 | 12 |
| 31 Mar 23 | 17,872 | 1,070 | 4,617 | 9 |
| 01 Jan 23 | 17,432 | 1,010 | 4,592 | 9 |
| 30 Sep 22 | 16,115 | 835 | 4,376 | 5 |
| 30 Jun 22 | 15,851 | 816 | 4,370 | 3 |
| 31 Mar 22 | 15,154 | 840 | 4,267 | 4 |
| 01 Jan 22 | 14,587 | 922 | 4,090 | 5 |
| 30 Sep 21 | 13,916 | 950 | 3,999 | 4 |
| 30 Jun 21 | 13,329 | 897 | 3,822 | 4 |
| 31 Mar 21 | 12,998 | 846 | 3,623 | 3 |
| 31 Dec 20 | 12,656 | 790 | 3,544 | 1 |
| 30 Sep 20 | 12,056 | 724 | 3,466 | 1 |
| 30 Jun 20 | 11,448 | 683 | 3,378 | 1 |
| 31 Mar 20 | 10,978 | 633 | 3,358 | 0 |
| 31 Dec 19 | 10,479 | 604 | 3,245 | 0 |
| 30 Sep 19 | 10,219 | 587 | 3,150 | 0 |
| 30 Jun 19 | 9,945 | 566 | 3,035 | 0 |
| 31 Mar 19 | 9,585 | 565 | 2,923 | 0 |
| 01 Jan 19 | 9,176 | 521 | 2,845 | 0 |
| 30 Sep 18 | 8,768 | 525 | 2,740 | 0 |
| 30 Jun 18 | 8,391 | 499 | 2,679 | 0 |
| 31 Mar 18 | 8,116 | 457 | 2,612 | 0 |
| 31 Dec 17 | 7,751 | 423 | 2,497 | 0 |
| 30 Sep 17 | 7,316 | 386 | 2,336 | 0 |
| 30 Jun 17 | 6,949 | 373 | 2,229 | 0 |
| 31 Mar 17 | 6,584 | 345 | 2,092 | 0 |
| 31 Dec 16 | 6,249 | 353 | 2,036 | 0 |
| 30 Sep 16 | 5,971 | 379 | 1,997 | 0 |
| 30 Jun 16 | 5,774 | 369 | 1,925 | 0 |
| 31 Mar 16 | 5,600 | 361 | 1,887 | 0 |
| 31 Dec 15 | 5,321 | 346 | 1,747 | 0 |
| 30 Sep 15 | 5,080 | 323 | 1,597 | 0 |
| 30 Jun 15 | 4,854 | 314 | 1,472 | 0 |
| 31 Mar 15 | 4,589 | 310 | 1,390 | 0 |
| 31 Dec 14 | 4,428 | 297 | 1,332 | 0 |
| 30 Sep 14 | 4,236 | 292 | 1,297 | 0 |
| 30 Jun 14 | 3,995 | 279 | 1,233 | 0 |
| 31 Mar 14 | 3,792 | 253 | 1,392 | 0 |
| 31 Dec 13 | 3,547 | 241 | 1,081 | 0 |
Quality Earnings: 002727 has high quality earnings.
Growing Profit Margin: 002727's current net profit margins (3.1%) are lower than last year (6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002727's earnings have grown by 7.5% per year over the past 5 years.
Accelerating Growth: 002727's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002727 had negative earnings growth (-48.4%) over the past year, making it difficult to compare to the Consumer Retailing industry average (-5.7%).
Return on Equity
High ROE: 002727's Return on Equity (6.9%) is considered low.